AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 279: H932-H938, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cherwek, D. H.
Right arrow Articles by Taylor, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherwek, D. H.
Right arrow Articles by Taylor, D. A.
Vol. 279, Issue 3, H932-H938, September 2000

Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia

D. Hunter Cherwek1, M. Benjamin Hopkins1, Michael J. Thompson2, Brian H. Annex2,3, and Doris A. Taylor1,2,4

Departments of 2 Medicine, 1 Surgery, and 4 Biomedical Engineering, Duke University Medical Center; and 3 Division of Cardiology, Durham Veterans Affairs Medical Center, Durham, North Carolina 27710

Alterations in endogenous levels of the angiogenic proteins basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) were assessed in rabbit hindlimb muscles subjected to 1, 5, or 21 days of ischemia. In the glycolytic [tibialis anterior (TA)] and the oxidative [soleus (SOL)] muscles from the ischemic and contralateral (control) hindlimb, bFGF and VEGF protein expression was determined by ELISA and immunoblot analysis. Total VEGF protein expression was greater in oxidative than in glycolytic muscles after 5 days of hindlimb ischemia. In SOL muscle, total VEGF detected by ELISA in ischemic limbs was increased to 137, 300, and 220% of control at 1, 5, and 21 days, respectively. However, in TA, total VEGF expression by ELISA was increased only at 1 and 5 days of ischemia to 140 and 134% of control, respectively. By immunoblotting, the expression of the 165-amino acid isoform (VEGF165) was initially decreased to 55% of control in ischemic SOL at 1 day but was increased to 250% of control at day 5 and remained at 155% at day 21. In TA, VEGF165 was increased to 260% of control at 1 day of ischemia but only to 150% of control by day 5. The only significant change in bFGF expression in either the oxidative or glycolytic muscles was a small increase (129% of control) at 21 days in SOL. This study demonstrates that the magnitude and direction of change in VEGF protein expression depend on VEGF subtype, muscle fiber type, and duration of ischemia. These findings suggest that strategies in therapeutic angiogenesis may need to differ depending on muscle fiber type.

vascular endothelial growth factor; basic fibroblast growth factor; angiogenesis; skeletal muscle


This article has been cited by other articles:


Home page
 DiabetesHome page
Y. Li, S. Hazarika, D. Xie, A. M. Pippen, C. D. Kontos, and B. H. Annex
In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia
Diabetes, March 1, 2007; 56(3): 656 - 665.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. Milkiewicz, O. Hudlicka, R. Shiner, S. Egginton, and M. D. Brown
Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat
J. Physiol., December 1, 2006; 577(2): 671 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. E. Waters, S. Rotevatn, P. Li, B. H. Annex, and Z. Yan
Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle
Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1342 - C1348.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. E. Waters, R. L. Terjung, K. G. Peters, and B. H. Annex
Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents
J Appl Physiol, August 1, 2004; 97(2): 773 - 780.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. Jensen, J. Bangsbo, and Y. Hellsten
Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle
J. Physiol., June 1, 2004; 557(2): 571 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Nusz, D. C. White, Q. Dai, A. M. Pippen, M. A. Thompson, G. B. Walton, C. J. Parsa, W. J. Koch, and B. H. Annex
Vascular rarefaction in peripheral skeletal muscle after experimental heart failure
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1554 - H1562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Pattwell, T. Ashton, A. McArdle, R. D. Griffiths, and M. J. Jackson
Ischemia and reperfusion of skeletal muscle lead to the appearance of a stable lipid free radical in the circulation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2400 - H2404.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online